Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions
This page documents how this source is reused across Claim by Claim. A source can support, challenge, qualify or contextualize different claims; appearing here does not imply endorsement of every linked proposition.
Evidence roles describe what this source helps establish inside each Investigation. They are local to that use, not permanent labels attached to the publication itself.
A 2022 Cell study analyzed 17,401 human tissue, blood and plasma samples across 35 cancer types, reporting low-abundance fungal signals with some histological validation; its human sampling establishes association and presence rather than universal fungal causation or clinical antifungal efficacy.